Skip to main content

Deferasirox versus deferoxamine.

Publication ,  Journal Article
Martin, MG; Arcasoy, MO
Published in: Blood
July 15, 2006

Duke Scholars

Published In

Blood

DOI

ISSN

0006-4971

Publication Date

July 15, 2006

Volume

108

Issue

2

Start / End Page

774 / 775

Location

United States

Related Subject Headings

  • Triazoles
  • Randomized Controlled Trials as Topic
  • Patient Compliance
  • Immunology
  • Humans
  • Deferoxamine
  • Deferasirox
  • Data Interpretation, Statistical
  • Benzoates
  • 3213 Paediatrics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Martin, M. G., & Arcasoy, M. O. (2006). Deferasirox versus deferoxamine. Blood, 108(2), 774–775. https://doi.org/10.1182/blood-2006-02-002436
Martin, Mike G., and Murat O. Arcasoy. “Deferasirox versus deferoxamine.Blood 108, no. 2 (July 15, 2006): 774–75. https://doi.org/10.1182/blood-2006-02-002436.
Martin MG, Arcasoy MO. Deferasirox versus deferoxamine. Blood. 2006 Jul 15;108(2):774–5.
Martin, Mike G., and Murat O. Arcasoy. “Deferasirox versus deferoxamine.Blood, vol. 108, no. 2, July 2006, pp. 774–75. Pubmed, doi:10.1182/blood-2006-02-002436.
Martin MG, Arcasoy MO. Deferasirox versus deferoxamine. Blood. 2006 Jul 15;108(2):774–775.

Published In

Blood

DOI

ISSN

0006-4971

Publication Date

July 15, 2006

Volume

108

Issue

2

Start / End Page

774 / 775

Location

United States

Related Subject Headings

  • Triazoles
  • Randomized Controlled Trials as Topic
  • Patient Compliance
  • Immunology
  • Humans
  • Deferoxamine
  • Deferasirox
  • Data Interpretation, Statistical
  • Benzoates
  • 3213 Paediatrics